Academic Trustees

The Board of Trustees includes two Academic Trustees.

  • Ian Craddock Academic Trustee
    Current post-holder: Professor Ian Craddock

    First appointed: 1 June 2021

    Current term of office ends: 31 July 2023


    Ian Craddock joined the University as an Engineering undergraduate in 1989 before undertaking a PhD in electromagnetics. Appointed to a lectureship and subsequently a Chair in Engineering he directed large programmes of research in breast cancer detection and in digital health. For 8 years he had a part time position in industry as Director of Toshiba’s Bristol Research Laboratory. He teaches undergraduate electromagnetics and directs two postgraduate programmes. Alongside research interests in machine learning and healthcare, he has initiated significant new activities in the areas of ethics, coproduction, diversity and inclusion. He is a REF panel member, Chartered Engineer, a Fellow of the IEEE and of the Alan Turing Institute.
  • Caroline Relton Academic Trustee
    Current post-holder: Professor Caroline Relton

    First appointed: 1 August 2021

    Current term of office ends: 31 July 2024


    Professor Caroline Relton is a Professor of Epigenetic Epidemiology. She obtained a PhD at Newcastle University in 1999 where she held an academic position for 12 years before moving to the University of Bristol in 2012. She is currently Director of the Bristol Population Health Science Institute (since 2017), Programme Lead in the MRC Integrative Epidemiology Unit (since 2013), joint lead of the CRUK Integrative Cancer Epidemiology Programme (since 2015) and Director of the Wellcome 4-Year PhD Programme in Molecular, Genetic and Lifecourse Epidemiology (since 2019). She is also Faculty Enterprise and Innovation Director for the Faculty of Health Sciences at the University of Bristol.

    Professor Relton's research focuses on understanding the role of both genetic and epigenetic variation in development and disease. Her group uses population-based approaches to study epigenetic information as a biomarker of exposure and a predictor of disease. Her research spans multiple clinical areas from perinatal health to cancer and includes studies of both the prevention and treatment of ill health. She has supervised over 20 PhD students and published over 275 scientific papers.

    Professor Relton serves on a range of grant funding panels, scientific advisory boards and committees within the UK and internationally.
Edit this page